NCT00189254View on ClinicalTrials.gov

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Actinic Keratoses
Interventions
DRUG

Imiquimod

No defined treatments were given during this study.

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00189254 - A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ | Biotech Hunter | Biotech Hunter